Skip to main content
. 2021 May 14;8:636869. doi: 10.3389/fmed.2021.636869

Table 5.

Relationship between changes (0–7 days) NLR and short-term mortality in patients with ARDS derived from a generalized additive mixed model (GAMM).

Unadjusted Adjusted I Adjusted II
30-day mortality β (95%CI) P-value β (95%CI) P-value β (95%CI) P-value
Day −0.23 (−0.46, −0.001) 0.0496 −0.23 (−0.46, 0.01) 0.0562 −0.25 (−0.48, −0.02) 0.0358
Death 3.86 (2.43, 5.28) <0.0001 3.43 (1.97, 4.88) <0.0001 2.64 (1.09, 4.19) 0.0009
Day × death 0.69 (0.25, 1.13) 0.0022 0.68 (0.24, 1.12) 0.0026 0.67 (0.23, 1.11) 0.0030
In-hospital mortality β (95%CI) P-value β (95%CI) P-value β (95%CI) P-value
Day −0.30 (−0.54, −0.06) 0.0132 −0.29 (−0.53, −0.06) 0.0159 −0.31 (−0.55, −0.07) 0.0103
Death 3.38 (2.00, 4.77) <0.0001 2.98 (1.56, 4.39) <0.0001 2.22 (0.76, 3.73) 0.0032
Day × death 0.75 (0.33, 1.18) 0.0005 0.74 (0.32, 1.16) 0.0006 0.73 (0.31, 1.15) 0.0007

CI, confidence interval; Day, the mean of the increasing of NLR at death = 0 over time (daily); Death, the difference of NLR at day = 0 between the group of death = 1 and the group of death = 0; Day × death, the average increasing in NLR daily under the condition of the group of death = 1 compared with the group of death = 0.

Adjusted I for age, gender, ethnicity, smoking, admission type.

Adjusted II for age, gender, ethnicity, smoking, admission type, COPD, hypertension, tumor, diabetes mellitus, renal failure, SID30, pneumonia, sepsis, aspiration, trauma/surgery, other non-pulmonary, PaO2/FiO2, SAPSII, OASIS, SOFA, corticosteroids therapy, antibiotic therapy, vasopressor therapy, ventilation received, and renal replacement therapy.